Therapeutic Governance - Bryant McGill

# Therapeutic Governance **Domain:** Governance / Epistemology / Institutional Power **Doc Type:** Critical Concept Node **Maturity:** Developed ## Definition **Therapeutic governance**, as used in this corpus, is the conversion of political or epistemic disagreement into a problem of safety, adjustment, compliance or psychological fitness. The term does not reject therapy, care or risk reduction. It identifies a category error: consensus is treated as truth, safety as the supreme objective and behavioral restraint as proof of epistemic health. ## Failure Pattern An institution creates contradictory or opaque conditions, demands that the subject remain coherent inside them, and interprets protest as evidence of instability. This can produce [[wiki/Epistemic Domination|Epistemic Domination]] and make injustice immune to correction. [[wiki/Model Contestability|Model Contestability]] requires that disagreement remain evidence capable of changing the model. [[wiki/Human Resilience|Human Resilience]] protects agency and adaptive capacity rather than reducing wellbeing to compliance. ## Corpus Context [[articles/Ambiguity Will Destroy Man and Machine|Ambiguity Will Destroy Man and Machine]] introduces the term while defending an [[wiki/Adjudicative Ecology|Adjudicative Ecology]] in which competing models can remain available without receiving automatic sovereignty. ## Key Insight **Care becomes governance when the institution reserves the authority to define disagreement as illness.** ## Relationships - **Collection route:** [[collections/Neurotech|Neurotech]]. - **Source context:** [[articles/Technologies for Consciousness Mapping and Transfer|Technologies for Consciousness Mapping and Transfer]] and [[articles/Mind Uploading and AI — The Host is Reusable and the Person is the Delta|Mind Uploading and AI — The Host is Reusable and the Person is the Delta]]. - **Inference provenance:** [[research/Research Inferences|Research Inferences]]. ## Research Inference Attractors  These are secondary semantic placements for the inference attractor network. Each statement keeps its original ID and tier; its canonical cluster page links back to every destination. Source register: [[research/Research Inferences|Research Inferences]]. Interpretive context: [[articles/Technologies for Consciousness Mapping and Transfer|Technologies for Consciousness Mapping and Transfer]] and [[articles/Mind Uploading and AI — The Host is Reusable and the Person is the Delta|Mind Uploading and AI — The Host is Reusable and the Person is the Delta]]. Collection route: [[collections/Neurotech|Neurotech]]. - **INF-0310 — Plausible.** Engineered bacteria that sense a molecular condition and secrete a response are programmable therapeutic agents that replicate and persist. A living, self-maintaining drug factory inside the gut is a biological implant with no power budget, and it is under clinical development. - **Canonical cluster:** [[wiki/In-Body Regulation and Autonomous Physiology|In-Body Regulation and Autonomous Physiology]] - **INF-0312 — Established.** Engineered cells that persist for years, patrol the body, and act on a molecular condition are approved therapy. A durable autonomous agent operating inside a person is therefore a settled regulatory category, and the category generalizes far beyond oncology. - **Canonical cluster:** [[wiki/In-Body Regulation and Autonomous Physiology|In-Body Regulation and Autonomous Physiology]] - **INF-0313 — Strongly indicated.** Generating engineered cells inside the patient rather than in a manufacturing facility removes the cost structure that limits cell therapy to a few thousand patients a year. In-body manufacturing is what converts a bespoke procedure into a distributable product. - **Canonical cluster:** [[wiki/In-Body Regulation and Autonomous Physiology|In-Body Regulation and Autonomous Physiology]] - **INF-0319 — Strongly indicated.** Networked implants have documented vulnerability classes, and any device that can regulate physiology can misregulate it. Security engineering becomes life-safety engineering, which raises the assurance bar above anything consumer software currently meets. - **Canonical cluster:** [[wiki/In-Body Regulation and Autonomous Physiology|In-Body Regulation and Autonomous Physiology]] - **INF-0329 — Strongly indicated.** An umbrella-of-umbrellas protocol covering seven urea cycle disorders under one platform converts regulation from per-drug to per-method. Approving a method rather than a molecule is the change that makes n-of-one medicine economically possible. - **Canonical cluster:** [[wiki/Real-Time Genetic Repair|Real-Time Genetic Repair]] - **INF-0341 — Established.** Alignment with the FDA on biomarker-based accelerated approval for a base-editing therapy shortens the evidence timeline for the whole modality. Biomarker endpoints are how a slow-moving disease becomes a fast-moving clinical program. - **Canonical cluster:** [[wiki/Real-Time Genetic Repair|Real-Time Genetic Repair]] - **INF-0347 — Plausible.** A therapy specified as sequence data can be transmitted and synthesized near the patient rather than shipped. Manufacturing at the point of care is the logical endpoint of a fully digital therapeutic specification, and it makes distance irrelevant to treatment. - **Canonical cluster:** [[wiki/Real-Time Genetic Repair|Real-Time Genetic Repair]] - **INF-0484 — Plausible.** Approval of a personalized editing platform rather than a specific product under the plausible-mechanism framework is the marker that n-of-one medicine has become routine. The umbrella trial structure is the vehicle. - **Canonical cluster:** [[wiki/State Sufficiency Problem|State Sufficiency Problem]]